Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales

Plazomicin (PLZ), brand name ZEMDRI (Cipla Therapeutics), is a novel aminoglycoside antibiotic approved by the U.S. Food and Drug Administration (FDA) for treatment of complicated urinary tract infections including pyelonephritis. ETEST® is a gradient diffusion method that represents an alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanchard, Laurine S., Van Belkum, Alex, Dechaume, Dominique, Armstrong, Thomas P., Emery, Christopher L., Ying, Yun X., Kresken, Michael, Pompilio, Marion, Halimi, Diane, Zambardi, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Bacteriology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769719/
https://www.ncbi.nlm.nih.gov/pubmed/34757833
http://dx.doi.org/10.1128/JCM.01831-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769719/
https://www.ncbi.nlm.nih.gov/pubmed/34757833
http://dx.doi.org/10.1128/JCM.01831-21

Ejemplares similares